Financial Gravity Companies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Financial Gravity Companies's BMY Position: Q2 2026 in Review
Financial Gravity Companies opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 137 shares worth $7.89K. The stake represents ﹤0.01% of the portfolio and ranks #624 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in BMY as recently as Q4 2018.
Financial Gravity Companies first reported a position in BMY in Q4 2017 and has held it in 4 quarters since. The position peaked at $90K in Q4 2018. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Financial Gravity Companies held 137 shares of Bristol-Myers Squibb worth $7.89K as of Q2 2026.
- Bristol-Myers Squibb was a new Financial Gravity Companies position in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Financial Gravity Companies's portfolio in Q2 2026, its #624 holding.
- Financial Gravity Companies first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 4 quarters since.
- Financial Gravity Companies's Bristol-Myers Squibb position peaked at $90K in Q4 2018.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Financial Gravity Companies's 13F filing for Q2 2026, filed 5 Aug 2026.